Objectives to investigate the effect of testosterone on the cerebral cortex Bcl-2 expression and oxidative stress in a rat model of vascular dementia (VD). Methods Forty-eight Sprague-Dawley adult male rats were divided into four groups (n=12, each) as follows (i) untreated control, (ii) rats exposed to surgical permanent bilateral occlusion of the common carotid arteries (BCCAO) leading to chronic cerebral hypoperfusion, (iii) rats exposed to BCCAO then received testosterone (0.5 mg/ kg S.C., three times/ week, S.C.) (BCCAO + Tes) for 4 weeks and (iv) rats exposed to BCCAO then received donepezil (3 mg/kg/ day; i.p.) (BCCAO + DON) for 4 weeks. Levels of acetylcholine and norepinephrine in the cerebral cortex were measured. Furthermore, the expression of Bcl-2 in the cerebral cortex and malondialdehyde (MDA), non-enzymatic (reduced glutathione, GSH) and enzymatic [superoxide dismutase (SOD) and catalase (CAT)] antioxidants were determined. Histopathological studies of the cerebral cortex were performed. Results BCCAO decreased the expression of Bcl-2 as well as the central level of acetylcholine and norepinephrine as compared to control rats. Also, increased the cerebral cortex level of MDA and decreased the enzymatic and non-enzymatic antioxidant. Treatment with testosterone and donepezil increased acetylcholine and norepinephrine significantly when compared with BCCAO rats. Testosterone significantly increased the expression of Bcl-2 and antioxidant system with significant reduction in MDA. Conclusion Testosterone might employ neuroprotective effects through increasing the expression of Bcl-2 as well as ameliorating the oxidative stress induced by BCCAO in rat model of DA.
Disorders of the cerebral circulation are the causes of numerous neurological and psychiatric illnesses. Reduction in regional cerebral blood flow (CBF) compromises memory processes and contributes towards the development and progression of dementia. The association of decreased CBF, particularly in the temporal and parietal cortices, with Alzheimer's disease (AD) has been firmly established. [1] [2] [3] Cerebral ischemia is associated with decreased partial pressure of oxygen (O 2 ) causes a reduction in available cellular O 2 , which is the ultimate electron acceptor in the electron transport chain. 4 The founder of this family, the BCL-2 proto-oncogene, was discovered at the chromosomal breakpoint that bearing human 
MATERIALS AND METHODS

Experimental Animals
Chemicals:
Testosterone propionate and donepezil (AChase inhibitor) were obtained from Sigma Aldrich.
Sample preparation and biochemical evaluations
The rats were euthanized after the end of the treatment. The brain was quickly removed from the skull; the hippocampus and the rest of the brain were dissected. 
Biochemical investigations
In the cerebral cortex tissue homogenate, 
Histological examination
The 
Statistical analysis
Statistical analysis was performed by using GraphPad Prism 6.0 (GraphPad Software Inc., San Diego, CA). The data were analyzed by One-way ANOVA, followed by the Tukey Multiple Comparison
Test for parametric data. Pearson correlation was made between Bcl-2 and measured parameters. P value of 0.05 or less was considered significant. GSH as compared to BCCAO rats.
RESULTS
Interestingly, this study showed that cerebral ischemia decreased the expression of the anti-apoptotic Bcl-2 expression significantly as compared to control rats.
Within a few minutes after ischemia, the neurons in ischemic core undergo irreversible injury. The cell death was traditionally thought to occur exclusively via necrosis; recent research indicated that apoptosis was the important cause of neuron death 29 , especially the cells in penumbra. 30 Clinical evidence showed that apoptosis occurred in the penumbral region from 1 to 26 days after stroke. 31 Thus, suppressing apoptosis at early stage after stroke may be an important opportunity for salvage of neurons in penumbra, and then reduce the infarct volume and alleviate brain injury induced by ischemia. 32, 33 In this study, testosterone significantly increased the expression of Bcl-2 as compared to BCCAO rats in cerebral cortex tissue. Testosterone deficiency in males was associated with conditions that indicate CNS neuronal dysfunction such as depression, anxiety and memory loss. 34 Furthermore, replacement therapy significantly improved these symptoms. Also, androgens offered as much neuroprotection against growth factor deprivation mediated neuronal apoptosis of CNS differentiated human neurons as 17bestradiol. 35 In partial agreement with our data, testosterone and its metabolite 5-α dihydrotestosterone regulated the expression of Bcl-2 in human dermal papilla cells. 36 In disagreement with our data previous studies strongly suggested a proapoptotic effect of testosterone. Crisostomo et al. 37 
